Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

John Corboy

Concepts (392)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Sclerosis
50
2025
460
8.620
 Why?
Multiple Sclerosis, Relapsing-Remitting
15
2025
76
3.670
 Why?
Immunologic Factors
13
2025
243
2.500
 Why?
Neurology
10
2018
111
2.240
 Why?
Immunosuppressive Agents
10
2024
849
1.570
 Why?
Neuromyelitis Optica
4
2023
134
1.120
 Why?
Natalizumab
11
2021
40
0.930
 Why?
Recurrence
8
2025
1084
0.880
 Why?
Diagnostic Errors
2
2017
174
0.700
 Why?
Brain
16
2025
2792
0.680
 Why?
Internship and Residency
5
2011
1187
0.650
 Why?
Drug Substitution
2
2019
56
0.640
 Why?
Fingolimod Hydrochloride
5
2020
40
0.620
 Why?
Rituximab
4
2020
202
0.590
 Why?
Data Collection
4
2011
657
0.580
 Why?
Dementia, Vascular
3
2009
20
0.570
 Why?
Drug Monitoring
1
2019
215
0.540
 Why?
Medication Adherence
2
2019
504
0.540
 Why?
Early Medical Intervention
1
2017
59
0.520
 Why?
Early Diagnosis
2
2017
239
0.510
 Why?
Magnetic Resonance Imaging
24
2025
3637
0.500
 Why?
Glatiramer Acetate
6
2019
18
0.490
 Why?
Humans
87
2025
138651
0.480
 Why?
Calcinosis
2
2009
238
0.480
 Why?
Physicians
4
2016
932
0.470
 Why?
Postural Balance
3
2018
217
0.450
 Why?
Antibodies, Monoclonal, Humanized
8
2023
815
0.430
 Why?
Fatigue
3
2018
336
0.380
 Why?
Dimethyl Fumarate
3
2020
12
0.360
 Why?
Immunoglobulin G
4
2023
898
0.350
 Why?
Middle Aged
39
2025
33604
0.330
 Why?
Multiple Sclerosis, Chronic Progressive
3
2020
28
0.320
 Why?
Practice Guidelines as Topic
1
2018
1567
0.320
 Why?
Withholding Treatment
2
2021
77
0.320
 Why?
Adult
43
2025
38201
0.310
 Why?
Psychiatry
2
2009
187
0.300
 Why?
Demyelinating Diseases
4
2019
85
0.280
 Why?
Cysts
1
2009
114
0.280
 Why?
HIV Long Terminal Repeat
3
2001
10
0.280
 Why?
Education, Medical
1
2011
268
0.270
 Why?
Autoantibodies
3
2023
1456
0.270
 Why?
Certification
1
2008
116
0.270
 Why?
Lymphopenia
2
2020
66
0.260
 Why?
Female
49
2025
73763
0.260
 Why?
Education
2
2007
108
0.260
 Why?
Central Nervous System Cysts
1
2006
13
0.260
 Why?
Clinical Trials as Topic
3
2016
1034
0.250
 Why?
Male
40
2025
68260
0.250
 Why?
Cerebral Arteries
1
2006
59
0.250
 Why?
Single-Blind Method
3
2023
286
0.250
 Why?
Myelin-Oligodendrocyte Glycoprotein
2
2023
53
0.250
 Why?
Cerebrovascular Disorders
1
2006
96
0.240
 Why?
DNA, Viral
2
1998
365
0.240
 Why?
Societies, Medical
4
2019
839
0.230
 Why?
Ethics, Medical
2
2015
85
0.230
 Why?
HIV Seropositivity
2
1998
126
0.230
 Why?
Treatment Outcome
12
2023
10923
0.220
 Why?
Drug Industry
2
2016
109
0.220
 Why?
Databases, Factual
3
2016
1415
0.210
 Why?
Double-Blind Method
4
2023
1949
0.210
 Why?
Conflict of Interest
2
2016
130
0.210
 Why?
AIDS Dementia Complex
3
2001
51
0.200
 Why?
Microglia
2
2024
255
0.200
 Why?
Encephalomyelitis, Autoimmune, Experimental
1
2023
68
0.190
 Why?
Heart Aneurysm
1
2002
12
0.190
 Why?
Quality of Health Care
2
2017
654
0.180
 Why?
Heart Septal Defects, Atrial
1
2002
58
0.180
 Why?
B-Lymphocytes
5
2023
855
0.180
 Why?
Interferon beta-1a
2
2019
12
0.180
 Why?
Lymphoma
2
2005
227
0.170
 Why?
Neuroimaging
1
2023
263
0.170
 Why?
Mental Disorders
2
2007
1096
0.170
 Why?
Education, Medical, Continuing
2
2015
132
0.170
 Why?
Central Nervous System Neoplasms
2
2005
165
0.170
 Why?
Agammaglobulinemia
1
2020
33
0.160
 Why?
Brain Neoplasms
4
2016
1267
0.160
 Why?
Interferon-gamma
1
2023
786
0.160
 Why?
Serum Sickness
1
2019
6
0.160
 Why?
Disease Progression
4
2021
2749
0.160
 Why?
Indans
1
2019
12
0.160
 Why?
Neutropenia
1
2020
157
0.160
 Why?
Oxadiazoles
1
2019
33
0.160
 Why?
Referral and Consultation
1
2005
793
0.150
 Why?
Diagnosis, Differential
4
2023
1482
0.150
 Why?
Lymphoma, AIDS-Related
1
1998
14
0.140
 Why?
Adjuvants, Immunologic
3
2015
237
0.140
 Why?
Salvage Therapy
1
2019
151
0.140
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
253
0.140
 Why?
Educational Measurement
3
2015
299
0.140
 Why?
Herpesvirus 8, Human
1
1998
66
0.140
 Why?
Diffuse Cerebral Sclerosis of Schilder
1
2017
4
0.130
 Why?
Eye Movements
1
2018
82
0.130
 Why?
Central Nervous System
2
2005
263
0.130
 Why?
Physician-Patient Relations
2
2016
581
0.130
 Why?
Patient Selection
2
2015
676
0.130
 Why?
Sarcoma, Kaposi
1
1998
79
0.130
 Why?
Young Adult
7
2024
13305
0.130
 Why?
Hematopoietic Stem Cell Transplantation
2
2019
661
0.130
 Why?
Herpesvirus 4, Human
1
2018
165
0.130
 Why?
Nervous System Diseases
2
2024
273
0.130
 Why?
Herpesviridae Infections
1
1998
148
0.130
 Why?
Suicide, Assisted
1
1997
26
0.130
 Why?
Neurologists
1
2016
22
0.130
 Why?
Aged
9
2024
24024
0.120
 Why?
Costs and Cost Analysis
1
2017
222
0.120
 Why?
Estriol
1
2015
6
0.120
 Why?
Cost-Benefit Analysis
2
2016
608
0.120
 Why?
Dizziness
2
2018
81
0.120
 Why?
Verbal Learning
2
2013
66
0.120
 Why?
Retrospective Studies
10
2024
15909
0.120
 Why?
Corpus Callosum
2
2006
70
0.120
 Why?
T-Lymphocytes
1
2023
1986
0.110
 Why?
Follow-Up Studies
6
2020
5112
0.110
 Why?
Trust
1
2016
144
0.110
 Why?
Diffusion Magnetic Resonance Imaging
2
2006
154
0.110
 Why?
Mesenchymal Stem Cell Transplantation
1
2014
60
0.110
 Why?
Medication Reconciliation
1
2013
30
0.100
 Why?
Insurance, Health
1
2016
296
0.100
 Why?
CD40 Antigens
1
2014
89
0.100
 Why?
Stroke
1
2002
1136
0.100
 Why?
Exercise Therapy
1
2018
439
0.100
 Why?
T-Lymphocytes, Helper-Inducer
1
2014
136
0.100
 Why?
JC Virus
1
2013
23
0.100
 Why?
Anti-Inflammatory Agents
2
2006
476
0.100
 Why?
Sensation Disorders
1
2012
37
0.100
 Why?
Immune Reconstitution Inflammatory Syndrome
1
2012
19
0.090
 Why?
Population Surveillance
1
2016
476
0.090
 Why?
Memory Disorders
1
2013
178
0.090
 Why?
Immunoglobulin Heavy Chains
3
2007
83
0.090
 Why?
Leukoencephalopathy, Progressive Multifocal
1
2012
37
0.090
 Why?
Lymphoma, T-Cell, Peripheral
1
2012
19
0.090
 Why?
HIV-1
2
2001
886
0.090
 Why?
Optic Nerve
2
2005
66
0.090
 Why?
T-Lymphocyte Subsets
1
2014
415
0.090
 Why?
Glioma
1
2016
407
0.090
 Why?
United States
8
2024
14938
0.090
 Why?
Gadolinium
4
2018
81
0.090
 Why?
Academies and Institutes
1
2011
55
0.080
 Why?
Self-Assessment
1
2011
75
0.080
 Why?
Learning
1
2015
422
0.080
 Why?
Nerve Regeneration
1
2010
57
0.080
 Why?
Fatal Outcome
3
2006
309
0.080
 Why?
Leukocytosis
1
2010
33
0.080
 Why?
Diagnostic Tests, Routine
1
2011
110
0.080
 Why?
Quality of Life
3
2021
2954
0.080
 Why?
Antigens, CD19
3
2007
129
0.080
 Why?
Cranial Nerve Neoplasms
1
1989
8
0.080
 Why?
Biomarkers
3
2014
4092
0.080
 Why?
Hemangioma, Cavernous
1
1989
14
0.080
 Why?
Optic Chiasm
1
1989
18
0.080
 Why?
Severity of Illness Index
3
2014
2851
0.080
 Why?
Central Nervous System Infections
1
2010
35
0.080
 Why?
Exercise Test
1
2012
622
0.080
 Why?
Disease Management
1
2013
622
0.080
 Why?
Guidelines as Topic
1
2011
272
0.070
 Why?
Spinal Cord
3
2023
373
0.070
 Why?
Physical Therapy Modalities
1
2011
308
0.070
 Why?
Neuroprotective Agents
1
2009
138
0.070
 Why?
Hospital-Physician Relations
1
2007
3
0.070
 Why?
Practice Patterns, Physicians'
1
2016
1323
0.070
 Why?
Immunoglobulin Variable Region
2
2004
79
0.070
 Why?
Workload
1
2009
162
0.070
 Why?
Neuropsychological Tests
2
2013
1058
0.070
 Why?
Vasculitis, Central Nervous System
1
2006
14
0.060
 Why?
CD4-Positive T-Lymphocytes
1
1993
1098
0.060
 Why?
Headache Disorders
1
2006
19
0.060
 Why?
Antibodies, Monoclonal
2
2011
1436
0.060
 Why?
Nerve Fibers, Myelinated
1
2006
48
0.060
 Why?
Medical Records
1
2007
180
0.060
 Why?
Methylprednisolone
1
2006
63
0.060
 Why?
Syndrome
2
2023
377
0.060
 Why?
Glial Fibrillary Acidic Protein
1
2006
102
0.060
 Why?
International Classification of Diseases
1
2007
138
0.060
 Why?
Antibody Formation
1
2007
298
0.060
 Why?
Huntington Disease
1
2007
63
0.060
 Why?
Intracranial Hemorrhages
1
2006
89
0.060
 Why?
Contrast Media
3
2018
463
0.060
 Why?
Herpes Zoster
1
2010
314
0.060
 Why?
Adolescent
8
2024
21564
0.060
 Why?
Aquaporin 4
1
2006
97
0.060
 Why?
DNA Mutational Analysis
1
2006
398
0.060
 Why?
Canada
2
2019
407
0.060
 Why?
Fellowships and Scholarships
1
2009
310
0.060
 Why?
Health Care Surveys
1
2007
565
0.060
 Why?
Cognition Disorders
1
2009
511
0.060
 Why?
Analysis of Variance
3
2015
1317
0.060
 Why?
RNA, Messenger
1
1992
2815
0.060
 Why?
Neurologic Examination
1
2005
128
0.060
 Why?
Teaching
1
2007
233
0.060
 Why?
Patient Compliance
1
2009
598
0.060
 Why?
Surveys and Questionnaires
4
2016
5803
0.050
 Why?
Program Evaluation
1
2009
916
0.050
 Why?
Affect
1
2007
312
0.050
 Why?
Erythrocytes
1
2010
701
0.050
 Why?
Colorado
2
2024
4555
0.050
 Why?
Central Nervous System Diseases
1
2005
72
0.050
 Why?
Simvastatin
1
2004
63
0.050
 Why?
Neutrophils
1
2010
1274
0.050
 Why?
Ophthalmoplegia
1
2003
13
0.050
 Why?
Proteoglycans
1
2004
109
0.050
 Why?
Prevalence
2
2024
2727
0.050
 Why?
Faculty, Medical
1
2006
290
0.050
 Why?
Diagnostic Techniques, Ophthalmological
1
2003
50
0.050
 Why?
B-Lymphocyte Subsets
1
2003
77
0.050
 Why?
Cyclophosphamide
1
2003
255
0.050
 Why?
Radiography
1
2005
841
0.050
 Why?
Neurodegenerative Diseases
1
2024
138
0.050
 Why?
Infusions, Intravenous
1
2023
411
0.050
 Why?
Academic Medical Centers
1
2005
514
0.050
 Why?
Patient Outcome Assessment
1
2023
131
0.050
 Why?
Anticoagulants
1
2006
667
0.050
 Why?
Students, Medical
1
2006
355
0.050
 Why?
Induced Pluripotent Stem Cells
1
2024
248
0.040
 Why?
Membrane Glycoproteins
1
2004
499
0.040
 Why?
Lymphoma, B-Cell
2
2005
127
0.040
 Why?
Single-Cell Analysis
1
2024
321
0.040
 Why?
Pain
1
2007
777
0.040
 Why?
CCAAT-Enhancer-Binding Proteins
1
2001
37
0.040
 Why?
Cross-Sectional Studies
1
2012
5520
0.040
 Why?
Dementia
1
2005
261
0.040
 Why?
Molecular Sequence Data
3
2004
2923
0.040
 Why?
Disability Evaluation
2
2014
299
0.040
 Why?
Peptides
3
2013
976
0.040
 Why?
Schools, Medical
1
2002
151
0.040
 Why?
Antibodies, Antinuclear
1
2001
66
0.040
 Why?
Time Factors
4
2018
6851
0.040
 Why?
Atrophy
1
2021
189
0.040
 Why?
Clinical Competence
1
2008
1149
0.040
 Why?
Proteasome Endopeptidase Complex
1
2001
159
0.040
 Why?
Mobility Limitation
1
2020
60
0.040
 Why?
Consensus
1
2023
685
0.040
 Why?
Venous Thrombosis
1
2002
190
0.040
 Why?
Child
5
2016
21921
0.040
 Why?
Interferon-beta
2
2011
92
0.040
 Why?
Lymphocyte Activation
1
2003
1148
0.040
 Why?
Antibodies, Viral
1
2023
649
0.040
 Why?
Maintenance Chemotherapy
1
2019
37
0.040
 Why?
Lipids
1
2023
675
0.040
 Why?
Cerebral Infarction
1
1998
49
0.040
 Why?
Induction Chemotherapy
1
2019
80
0.040
 Why?
Cell Separation
2
2014
317
0.040
 Why?
HIV Seronegativity
1
1998
30
0.040
 Why?
Genes, myc
1
1998
48
0.030
 Why?
Base Sequence
2
2001
2174
0.030
 Why?
Transplantation, Autologous
1
2019
275
0.030
 Why?
Astrocytoma
1
1998
128
0.030
 Why?
In Situ Hybridization
1
2018
319
0.030
 Why?
Gene Library
1
1997
118
0.030
 Why?
Risk Assessment
1
2006
3433
0.030
 Why?
Real-Time Polymerase Chain Reaction
1
2018
346
0.030
 Why?
Gene Rearrangement
1
1998
151
0.030
 Why?
Breast Neoplasms
1
2008
2212
0.030
 Why?
Syndecan-1
2
2007
36
0.030
 Why?
Managed Care Programs
1
1997
140
0.030
 Why?
Drug Administration Schedule
1
2018
768
0.030
 Why?
Morals
1
1997
75
0.030
 Why?
Risk Factors
3
2008
10252
0.030
 Why?
Viral Load
1
2018
495
0.030
 Why?
Flow Cytometry
2
2014
1192
0.030
 Why?
Mutation
1
2006
3987
0.030
 Why?
Polymerase Chain Reaction
1
1998
1047
0.030
 Why?
Survival Analysis
1
2018
1309
0.030
 Why?
Sequence Analysis, DNA
1
1997
819
0.030
 Why?
Health Knowledge, Attitudes, Practice
2
2016
1374
0.030
 Why?
Child, Preschool
3
2016
11158
0.030
 Why?
Incidence
1
2020
2747
0.030
 Why?
Patient Care Team
1
2019
647
0.030
 Why?
Congresses as Topic
1
2015
227
0.030
 Why?
Propylene Glycols
1
2013
27
0.020
 Why?
Ocular Physiological Phenomena
1
1992
10
0.020
 Why?
HLA-DR Antigens
1
2014
228
0.020
 Why?
Sphingosine
1
2013
45
0.020
 Why?
Quality-Adjusted Life Years
1
2013
110
0.020
 Why?
beta-Galactosidase
1
1992
78
0.020
 Why?
Drug Therapy, Combination
1
2015
1032
0.020
 Why?
Markov Chains
1
2013
126
0.020
 Why?
Mice, Inbred DBA
1
1992
199
0.020
 Why?
Leukocyte Count
1
1993
326
0.020
 Why?
Haplotypes
1
2014
495
0.020
 Why?
Organ Specificity
1
1992
310
0.020
 Why?
Reference Values
1
2013
799
0.020
 Why?
Comparative Effectiveness Research
1
2013
156
0.020
 Why?
Mental Recall
1
2013
207
0.020
 Why?
CD3 Complex
1
2012
104
0.020
 Why?
Ki-67 Antigen
1
2012
111
0.020
 Why?
Mice
2
2023
17814
0.020
 Why?
Thymus Gland
1
1992
314
0.020
 Why?
Intestine, Small
1
1992
156
0.020
 Why?
Mitoxantrone
1
2011
14
0.020
 Why?
Animals
3
2023
37217
0.020
 Why?
Hematologic Tests
1
2011
22
0.020
 Why?
Muscle Stretching Exercises
1
2011
19
0.020
 Why?
Patient Participation
1
2015
428
0.020
 Why?
Depression
2
2011
1466
0.020
 Why?
Clinical Laboratory Techniques
1
2011
95
0.020
 Why?
Recombinant Fusion Proteins
1
1992
663
0.020
 Why?
Amino Acid Sequence
2
2004
2155
0.020
 Why?
Physical Endurance
1
2011
273
0.020
 Why?
Acyclovir
1
2010
95
0.020
 Why?
Randomized Controlled Trials as Topic
2
2006
1518
0.020
 Why?
Spinal Cord Neoplasms
1
1989
39
0.020
 Why?
Cell Count
1
2010
325
0.020
 Why?
Aged, 80 and over
2
2016
7677
0.020
 Why?
History, 19th Century
1
2009
61
0.020
 Why?
Respiratory Function Tests
1
2011
561
0.020
 Why?
Neoplasms, Multiple Primary
1
1989
57
0.020
 Why?
Injections
1
2009
189
0.020
 Why?
History, 21st Century
1
2009
214
0.020
 Why?
Pilot Projects
2
2004
1765
0.020
 Why?
Autoimmunity
1
2014
903
0.020
 Why?
Electrocardiography
1
2011
612
0.020
 Why?
History, 20th Century
1
2009
323
0.020
 Why?
Gene Expression
1
1992
1488
0.020
 Why?
Age of Onset
1
2009
514
0.020
 Why?
Mice, Transgenic
1
1992
2172
0.020
 Why?
Health
1
2007
84
0.020
 Why?
Memory
1
2009
258
0.020
 Why?
Association Learning
1
2007
63
0.020
 Why?
Herpesvirus 3, Human
1
2010
331
0.020
 Why?
Walking
1
2011
535
0.020
 Why?
Cerebral Ventricles
1
2006
54
0.020
 Why?
Prognosis
2
2006
3984
0.020
 Why?
Motor Skills
1
2007
100
0.020
 Why?
CD8-Positive T-Lymphocytes
1
2012
905
0.020
 Why?
Hypothalamus
1
2006
153
0.010
 Why?
Phenotype
1
2014
3139
0.010
 Why?
Genetics
1
2005
24
0.010
 Why?
Models, Theoretical
1
2009
578
0.010
 Why?
Immunologic Memory
1
2007
357
0.010
 Why?
Neurosciences
1
2005
25
0.010
 Why?
Hospitalization
1
2015
2235
0.010
 Why?
Social Support
1
2009
625
0.010
 Why?
Syndecans
1
2004
5
0.010
 Why?
Clinical Protocols
1
2006
273
0.010
 Why?
Anisotropy
1
2004
77
0.010
 Why?
Image Interpretation, Computer-Assisted
1
2006
272
0.010
 Why?
Internet
1
2009
669
0.010
 Why?
Immune System
1
2005
181
0.010
 Why?
Plasma Cells
1
2004
73
0.010
 Why?
Antiviral Agents
1
2010
735
0.010
 Why?
Gene Rearrangement, B-Lymphocyte, Light Chain
1
2003
4
0.010
 Why?
Gene Rearrangement, B-Lymphocyte, Heavy Chain
1
2003
11
0.010
 Why?
Infrared Rays
1
2003
26
0.010
 Why?
Meningitis, Viral
1
2003
20
0.010
 Why?
Videotape Recording
1
2003
39
0.010
 Why?
Saccades
1
2003
42
0.010
 Why?
Antilymphocyte Serum
1
2003
59
0.010
 Why?
Oligoclonal Bands
1
2003
20
0.010
 Why?
Antigens, CD34
1
2003
89
0.010
 Why?
Clone Cells
1
2003
265
0.010
 Why?
Whole-Body Irradiation
1
2003
78
0.010
 Why?
Astrocytes
1
2005
216
0.010
 Why?
Receptors, Antigen, B-Cell
1
2003
133
0.010
 Why?
Immunoglobulins
1
2003
168
0.010
 Why?
Observer Variation
1
2003
350
0.010
 Why?
Lymphoma, Large B-Cell, Diffuse
1
2005
184
0.010
 Why?
Feasibility Studies
1
2006
980
0.010
 Why?
Mice, Inbred C57BL
1
1992
5798
0.010
 Why?
Administration, Oral
1
2004
788
0.010
 Why?
Longitudinal Studies
1
2009
2844
0.010
 Why?
ATPases Associated with Diverse Cellular Activities
1
2001
8
0.010
 Why?
Age Factors
1
2009
3256
0.010
 Why?
Tomography, X-Ray Computed
1
2012
2698
0.010
 Why?
Sex Characteristics
1
2007
770
0.010
 Why?
Consensus Sequence
1
2001
73
0.010
 Why?
Cytomegalovirus Infections
1
2003
195
0.010
 Why?
Biopsy
1
2005
1072
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2003
984
0.010
 Why?
Immunoglobulin kappa-Chains
1
2001
22
0.010
 Why?
Infant
1
2015
9574
0.010
 Why?
Immunoglobulin Fab Fragments
1
2001
59
0.010
 Why?
Urinary Tract Infections
1
2003
193
0.010
 Why?
Gene Expression Regulation, Viral
1
2001
99
0.010
 Why?
Cohort Studies
1
2011
5697
0.010
 Why?
Predictive Value of Tests
1
2006
2030
0.010
 Why?
Acute Disease
1
2003
994
0.010
 Why?
Research
1
2003
451
0.010
 Why?
Combined Modality Therapy
1
2003
1235
0.010
 Why?
Lung
1
1992
4106
0.010
 Why?
Arachnoid
1
1998
12
0.010
 Why?
Sensitivity and Specificity
1
2003
1941
0.010
 Why?
Survival Rate
1
2003
1935
0.010
 Why?
Monocytes
1
2001
573
0.010
 Why?
Virus Replication
1
2001
527
0.010
 Why?
Models, Biological
1
2005
1806
0.010
 Why?
Binding Sites
1
2001
1313
0.010
 Why?
Case-Control Studies
1
2004
3523
0.010
 Why?
Aging
1
2007
1855
0.010
 Why?
Reproducibility of Results
1
2003
3307
0.010
 Why?
Transcription, Genetic
1
2001
1470
0.010
 Why?
DNA-Binding Proteins
1
2001
1471
0.010
 Why?
Cells, Cultured
1
2001
4181
0.010
 Why?
Corboy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (392) concept(s)
_
Co-Authors Expand Description
See all (39) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)